Lions Gate Entertainment(LGF_B) - 2026 Q3 - Quarterly Results
2026-02-26 21:08
Starz Entertainment Corp. Reports Results for the Fourth Quarter Ended December 31, 2025 Grew Fourth Quarter Revenue Sequentially to $322.8 Million Fourth Quarter Operating Loss Improved to $(4.7) Million Grew Fourth Quarter Adjusted OIBDA to $55.5 Million Operating Loss on a Trailing-Twelve Month Basis was $(208.7) Million Achieved $204.0 Million in Annual Trailing-Twelve Month Adjusted OIBDA Exhibit 99.1 Management Achieved or Exceeded All Previously Provided 2025 Outlook Grew OTT and Total Subscribers Se ...
Starz Entertainment Corp(STRZ) - 2026 Q3 - Quarterly Results
2026-02-26 21:08
Starz Entertainment Corp. Reports Results for the Fourth Quarter Ended December 31, 2025 Grew Fourth Quarter Revenue Sequentially to $322.8 Million Fourth Quarter Operating Loss Improved to $(4.7) Million Grew Fourth Quarter Adjusted OIBDA to $55.5 Million Operating Loss on a Trailing-Twelve Month Basis was $(208.7) Million Achieved $204.0 Million in Annual Trailing-Twelve Month Adjusted OIBDA Management Achieved or Exceeded All Previously Provided 2025 Outlook Grew OTT and Total Subscribers Sequentially by ...
Lions Gate Entertainment(LGF_A) - 2026 Q3 - Quarterly Results
2026-02-26 21:08
Exhibit 99.1 Starz Entertainment Corp. Reports Results for the Fourth Quarter Ended December 31, 2025 See "Use of Non-GAAP Financial Measures" for a definition of Free Cash Flow. 1 Grew Fourth Quarter Revenue Sequentially to $322.8 Million Fourth Quarter Operating Loss Improved to $(4.7) Million Grew Fourth Quarter Adjusted OIBDA to $55.5 Million Operating Loss on a Trailing-Twelve Month Basis was $(208.7) Million Achieved $204.0 Million in Annual Trailing-Twelve Month Adjusted OIBDA Management Achieved or ...
Fox(FOXF) - 2025 Q4 - Annual Results
2026-02-26 21:08
Exhibit 99.1 Fox Factory Holding Corp. Reports Fourth Quarter Fiscal 2025 Financial Results Announces Phase 2 of Profit Optimization Plan with Targeted Incremental Savings of Approximately $40 Million to be Realized in 2026 DULUTH, Georgia, February 26, 2026 - Fox Factory Holding Corp. (NASDAQ: FOXF) ("FOX" or the "Company"), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today reported financial results ...
Brink(BCO) - 2025 Q4 - Annual Results
2026-02-26 21:08
P R E S S R E L E A S E Contact: Investor Relations 804.289.9709 Brink's Announces Fourth-Quarter and Full-Year 2025 Results Fourth quarter revenue growth of 9% with organic growth of 5% Accelerating AMS/DRS fourth quarter organic growth to 22% Record 2025 cash generation with cash from operations of $640M and free cash flow of $436M Reduced net debt leverage to 2.7x Adjusted EBITDA RICHMOND, Va., February 26, 2026 – The Brink's Company (NYSE:BCO), a leading global provider of cash and valuables management, ...
Emergent BioSolutions(EBS) - 2025 Q4 - Annual Results
2026-02-26 21:08
EMERGENT BIOSOLUTIONS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS GAITHERSBURG, Md., February 26, 2026—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2025. "Emergent's 2025 results demonstrate significant progress executing our multi-year turnaround strategy, delivering improved operating margins, strong adjusted EBITDA of $205 million, increased cash flow and lower leverage," said Joe Papa, president and CEO of Emergent. " ...
EPAM(EPAM) - 2025 Q4 - Annual Report
2026-02-26 21:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-35418 EPAM SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 22-3536104 (State or other jurisdiction of incorporation or organization) 41 University ...
Solventum Corporation(SOLV) - 2025 Q4 - Annual Results
2026-02-26 21:08
Exhibit 99.1 Organic sales growth in the quarter reflects positive performance from all segments, primarily driven by results of the Infection Prevention and Surgical Solutions business within MedSurg as well as Dental Solutions. GAAP and adjusted operating income margin remained largely consistent with prior year. On an adjusted basis, operating expense savings and the accretive benefit of the Purification and Filtration divestiture more than offset incremental tariff headwinds. Debt paydown following the ...
Sunrun(RUN) - 2025 Q4 - Annual Results
2026-02-26 21:08
Financial Performance - Net change in cash and restricted cash was $81 million, with Cash Generation of $187 million in Q4 2025, marking the fourth consecutive quarter of positive cash generation [12][24]. - Total revenue for Q4 2025 was $1,158.8 million, up 124% from Q4 2024, driven by a significant increase in Energy systems and product sales revenue [19]. - Net income attributable to common stockholders was $103.6 million, or $0.45 per basic share in Q4 2025 [20]. - The net loss for Q4 2025 was $175,106, a decrease from a net loss of $3,399,951 in Q4 2024, indicating an improvement in financial performance [33]. - Total operating expenses for Q4 2025 were $1,061.5 million, a decrease of 72% compared to Q4 2024 [20]. - Cash Generation for Q4 2025 reached $187 million, a substantial increase from $34 million in Q4 2024, reflecting enhanced cash flow management [43]. - The company reported a net cash used in investing activities of $408.9 million in Q4 2025, down from $792.4 million in Q4 2024, highlighting a reduction in capital expenditures [36]. Subscriber Metrics - Aggregate Subscriber Value was $1.3 billion in Q4 2025, an 18% decrease compared to Q4 2024 [12]. - Subscriber Additions were 25,475 in Q4 2025, a 17% decrease compared to Q4 2024, with total Subscribers reaching 997,280 [8]. - Storage Attachment Rate reached a record 71% in Q4 2025, up from 62% in the prior-year period [5][10]. - Subscriber value for Q4 2024 was $50,998, expected to increase to $52,206 in Q1 2025 and $53,891 in Q2 2025 [47]. - Customer additions in Q4 2024 totaled 32,932, with expectations of 27,773 by Q4 2025 [49]. Future Projections - Cash Generation outlook for full year 2026 is expected to be in the range of $250 million to $450 million [1][17]. - Contracted Net Value Creation is expected to be in the range of $650 million to $1,050 million for full year 2026 [17]. - Net earning assets are projected to grow from $6,766 million in Q4 2024 to $8,538 million by Q4 2025 [49]. - Basic shares outstanding are projected to increase from 225.7 million in Q4 2024 to 233.6 million by Q4 2025 [49]. Operational Efficiency - Aggregate Creation Costs for Q4 2025 were $1.046 billion, down from $1.169 billion in Q4 2024, indicating improved operational efficiency [40]. - Payments for the costs of energy systems in Q4 2025 were $409.6 million, a decrease from $791.8 million in Q4 2024, reflecting cost control measures [36]. - Total operating expenses for Q4 2025 were $1.061 billion, up from $721 million in Q3 2025, indicating increased investment in operations [40]. Strategic Focus - The company aims to enhance its market share and customer value proposition through new product offerings and strategic partnerships [28]. - Sunrun's strategy focuses on becoming a margin-focused, multi-product, customer-oriented company to improve profitability [28]. Environmental Impact - Positive Environmental Impact from Customers is quantified in millions of metric tons of avoided carbon emissions, showcasing the company's sustainability efforts [85].
Seer(SEER) - 2025 Q4 - Annual Results
2026-02-26 21:08
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook REDWOOD CITY, Calif. February 26, 2026 – Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent Highlights "2025 was a challenging year as our customers navigated ongoing budgetary pressures, including uncertainty around NIH funding in the fourth quarter," said Omid ...